China, Oct. 15 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Study to Predict Early Response to BCG Treatment in High-Risk Non-Muscle-Invasive Bladder Cancer'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600134420
Registration Time: 2026/10/14
Type: Observational study
Primary Sponsor: Shanghai Tenth People's Hospital
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=347528
Published by HT Digital Content Services with permission from Health Daily Digest....